UrsodeoxycholicAcid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 UrsodeoxycholicAcidCombined With Total Glucosides of Paeony in the Treatment of PBC With AIH Featur ...
A Randomized Controlled Open-label Clinical Trial of UrsodeoxycholicAcid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 A Randomized Controlled Open-label Clinical Trial of UrsodeoxycholicAcidCombined With Total Glucosi ...
Hepatitis;Primary Biliary Cholangitis;Autoimmune
Drug: Ursodeoxycholicacid combined with total glucosides of paeony;Drug: Ursodeoxycholicacidonly
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
Biochemical Response of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Induced by UrsodeoxycholicAcidOnly or Combination Therapy of Immunosuppressive Agents Biochemical Response of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Induced by ...
Randomized controlled study of ursodeoxycholicacid (UDCA) with or without bezafibrate in primary biliary cirrhosis Randomized controlled study of ursodeoxycholicacid(UDCA) with or without bezafibrate in primary bil ...
Randomized controlled study of ursodeoxycholicacid (UDCA) with or without bezafibrate in primary biliary cirrhosis - GLSG,2004,PBC Randomized controlled study of ursodeoxycholicacid(UDCA) with or without bezafibrate in primary bil ...
Primary biliary cirrhosis
Intervention:UDCA+Bezafibrate Bezafibrate: 400mg/day for 12 months Dose of pretreatment UDCA is not changed after entry. control:UDCA only Dose of pretreatment UDCA is not changed after entry. Intervention:UDCA+Bezafibrate Bezafibrate: 400mg/day for 12 months Dose of pretreatment UDCA is not ch ...